And now Catalina Res has a whole bunch of angry shareholders because one of the Directors, in the public domain, indicated that the upcoming assays would be exceptional and contain elements of significance. In reality, that was far from the actual result. Now, whether that was ill-informed or just plain stupid, shareholders are baying for blood, and they have every right to. A Director of a company has extra responsibilities and needs to be mindful about anything they say in relation to the company's activities. If CTN want to make any sort of headway, they need to heed what has just happened, or they will, quite simply, cease to exist.